AIMEE MURPHY: Open Payments
NPI 1447565734 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$462 in 23 payments from 8 companies in 2025. Trend: 2023 $502 · 2024 $729 · 2025 $462
Food & beverage: $462
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $121 |
| Novartis Pharmaceuticals Corporation | 5 | $117 |
| Novo Nordisk Inc | 4 | $62 |
| SANOFI-AVENTIS U.S. LLC | 3 | $56 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| ABBVIE INC. | 1 | $30 |
| Astellas Pharma US Inc | 1 | $28 |
| PFIZER INC. | 1 | $14 |
Products named: LEQVIO, EVENITY, TZIELD, Wegovy, Repatha, SHINGRIX, QULIPTA, Veozah.
Industry payments across GA — which companies pay providers there.
